Tracking cardiac troponin dynamics in patients treated with immune checkpoint inhibitors
Eduardo Zatarain‐Nicolás(Hospital General Universitario Gregorio Marañón), Ana Martín‐Garcia(Complejo Hospitalario de Salamanca), T Lozano Palencia(Hospital General Universitario de Alicante Doctor Balmis), Cristina Mitroi(Hospital Universitario Puerta de Hierro Majadahonda), Pablo Vadillo Martín(Spanish National Centre for Cardiovascular Research), Carlo G. Tocchetti(Federico II University Hospital), Carlos Flores(Complejo Hospitalario de Salamanca), Laura Gutiérrez-Sainz(Hospital Universitario La Paz), Juan Virizuela Echaburu(Hospital Universitario Virgen Macarena), Sara Ramírez(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Natividad Martínez-Banaclocha(Hospital General Universitario de Alicante Doctor Balmis), J Saldana Garcia(Hospital Universitario La Paz), Benito García(Hospital Universitario Puerta de Hierro Majadahonda), M Chaparro Munoz(Hospital Universitario Virgen Macarena)
Cited by 0
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal - Cardiovascular Imaging|2022|486
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
|European Journal of Heart Failure|2020|364